Veritable’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-12,725
| Closed | -$6.64M | – | 724 |
|
|
2023
Q2 | $6.64M | Sell |
12,725
-196
| -2% | -$106K | 0.1% | 100 |
|
|
2023
Q1 | $7.45M | Buy |
12,921
+29
| +0.2% | +$16.3K | 0.12% | 85 |
|
|
2022
Q4 | $7.1M | Buy |
12,892
+399
| +3% | +$211K | 0.12% | 86 |
|
|
2022
Q3 | $6.34M | Sell |
12,493
-1,126
| -8% | -$630K | 0.12% | 91 |
|
|
2022
Q2 | $7.4M | Buy |
13,619
+450
| +3% | +$248K | 0.13% | 87 |
|
|
2022
Q1 | $7.78M | Buy |
13,169
+173
| +1% | +$99.4K | 0.12% | 92 |
|
|
2021
Q4 | $8.67M | Buy |
12,996
+47
| +0.4% | +$29.3K | 0.13% | 85 |
|
|
2021
Q3 | $7.4M | Sell |
12,949
-114
| -0.9% | -$62.6K | 0.12% | 92 |
|
|
2021
Q2 | $6.59M | Sell |
13,063
-66
| -0.5% | -$31.1K | 0.11% | 99 |
|
|
2021
Q1 | $5.99M | Sell |
13,129
-757
| -5% | -$361K | 0.1% | 102 |
|
|
2020
Q4 | $6.47M | Sell |
13,886
-1,035
| -7% | -$485K | 0.12% | 95 |
|
|
2020
Q3 | $6.59M | Sell |
14,921
-151
| -1% | -$62.4K | 0.13% | 85 |
|
|
2020
Q2 | $5.46M | Sell |
15,072
-797
| -5% | -$267K | 0.12% | 93 |
|
|
2020
Q1 | $4.5M | Sell |
15,869
-1,148
| -7% | -$362K | 0.11% | 102 |
|
|
2019
Q4 | $5.53M | Buy |
17,017
+355
| +2% | +$108K | 0.1% | 117 |
|
|
2019
Q3 | $4.85M | Sell |
16,662
-146
| -0.9% | -$41.8K | 0.09% | 122 |
|
|
2019
Q2 | $4.94M | Sell |
16,808
-316
| -2% | -$87K | 0.1% | 120 |
|
|
2019
Q1 | $4.69M | Buy |
17,124
+278
| +2% | +$69.2K | 0.09% | 124 |
|
|
2018
Q4 | $3.77M | Buy |
16,846
+58
| +0.3% | +$13.6K | 0.09% | 133 |
|
|
2018
Q3 | $4.1M | Buy |
16,788
+314
| +2% | +$72.2K | 0.08% | 139 |
|
|
2018
Q2 | $3.41M | Buy |
16,474
+259
| +2% | +$55K | 0.07% | 151 |
|
|
2018
Q1 | $3.35M | Buy |
16,215
+1,097
| +7% | +$230K | 0.07% | 150 |
|
|
2017
Q4 | $2.87M | Sell |
15,118
-3,574
| -19% | -$685K | 0.06% | 165 |
|
|
2017
Q3 | $3.54M | Sell |
18,692
-460
| -2% | -$83.3K | 0.07% | 147 |
|
|
2017
Q2 | $3.34M | Buy |
19,152
+4,668
| +32% | +$784K | 0.08% | 153 |
|
|
2017
Q1 | $2.23M | Sell |
14,484
-18
| -0.1% | -$2.75K | 0.05% | 192 |
|
|
2016
Q4 | $2.05M | Buy |
14,502
+154
| +1% | +$22.7K | 0.05% | 202 |
|
|
2016
Q3 | $2.28M | Buy |
14,348
+1,305
| +10% | +$201K | 0.06% | 181 |
|
|
2016
Q2 | $1.93M | Buy |
13,043
+1,018
| +8% | +$150K | 0.05% | 206 |
|
|
2016
Q1 | $1.7M | Buy |
12,025
+1,143
| +11% | +$153K | 0.04% | 215 |
|
|
2015
Q4 | $1.54M | Buy |
10,882
+46
| +0.4% | +$6.13K | 0.04% | 230 |
|
|
2015
Q3 | $1.32M | Buy |
10,836
+256
| +2% | +$33.4K | 0.04% | 238 |
|
|
2015
Q2 | $1.37M | Sell |
10,580
-43,018
| -80% | -$5.61M | 0.04% | 248 |
|
|
2015
Q1 | $7.2M | Buy |
53,598
+39,271
| +274% | +$5.06M | 0.15% | 111 |
|
|
2014
Q4 | $1.79M | Sell |
14,327
-15,187
| -51% | -$1.85M | 0.04% | 280 |
|
|
2014
Q3 | $3.59M | Buy |
29,514
+541
| +2% | +$65.8K | 0.08% | 176 |
|
|
2014
Q2 | $3.42M | Buy |
28,973
+1,279
| +5% | +$151K | 0.07% | 184 |
|
|
2014
Q1 | $3.33M | Buy |
27,694
+124
| +0.4% | +$14.7K | 0.07% | 184 |
|
|
2013
Q4 | $3.07M | Sell |
27,570
-7,909
| -22% | -$786K | 0.07% | 186 |
|
|
2013
Q3 | $3.27M | Sell |
35,479
-6,462
| -15% | -$584K | 0.08% | 176 |
|
|
2013
Q2 | $3.55M | Buy |
+41,941
| New | +$3.49M | 0.09% | 166 |
|
Other funds holding TMO
Veritable's TMO Position: Q3 2023 in Review
Veritable sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 12,725 shares — an estimated $6.64M sold.
Veritable first reported a position in TMO in Q2 2013 and held it in 41 quarters. The position peaked at $8.67M in Q4 2021. 2,364 funds tracked by Wall St. Rank hold TMO as of Q3 2023.
- Veritable reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
- Veritable sold 12,725 Thermo Fisher Scientific shares in Q3 2023, an estimated $6.64M.
- Veritable first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 41 quarters.
- Veritable's Thermo Fisher Scientific position peaked at $8.67M in Q4 2021.
- 2,364 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.
Based on Veritable's 13F filing for Q3 2023.